Meta-Analysis: Reduced Risk of Anxiety with Psychostimulant Treatment in Children with Attention-Deficit/Hyperactivity Disorder.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of child and adolescent psychopharmacology

• Publication date

  2015-10-20

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1089/cap.2015.0075PMID 26402485PMCID PMC4617411
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Methylphenidate Reduces State Anxiety During a Continuous Performance Test That Distinguishes Adult ADHD Patients From Controls

  2017cited by this paper
• Clinical practice. Attention deficit-hyperactivity disorder in children and adolescents.

  2014cited by this paper
• Anxiety in Children With Attention-Deficit/Hyperactivity Disorder

  2014cited by this paper
• Methylphenidate treatment in children with attention deficit hyperactivity disorder and comorbid social phobia

  2014cited by this paper
• Relation between therapeutic response and side effects induced by methylphenidate as observed by parents and teachers of children with ADHD

  2011cited by this paper
• Clinical Response to Methylphenidate in Children Diagnosed with Attention-Deficit Hyperactivity Disorder and Comorbid Psychiatric Disorders

  2010cited by this paper
• Efficacy and Safety of Dexmethylphenidate Extended-Release Capsules Administered Once Daily to Children with Attention-Deficit/Hyperactivity Disorder

  2009cited by this paper
• The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

  2009cited by this paper
• The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

  2009cited by this paper
• Stimulant Drug Response in the Predominantly Inattentive and Combined Subtypes of Attention-Deficit/Hyperactivity Disorder

  2009cited by this paper
• Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response.

  2008cited by this paper
• Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.

  2006cited by this paper
• Effects of methylphenidate on subtypes of attention-deficit/hyperactivity disorder.

  2006cited by this paper
• Safety and tolerability of methylphenidate in preschool children with ADHD.

  2006cited by this paper
• Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders.

  2005cited by this paper
• A double-blind, placebo-controlled trial of dexmethylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in children with attention-deficit/hyperactivity disorder.

  2004cited by this paper
• Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (Adderall XR), in children with ADHD.

  2003cited by this paper
• A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.

  2003cited by this paper
• A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit/hyperactivity disorder.

  2002cited by this paper
• A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit/hyperactivity disorder.

  2002cited by this paper
• Anxiety as a Predictor and Outcome Variable in the Multimodal Treatment Study of Children with ADHD (MTA)

  2000cited by this paper
• A double-blind, placebo-controlled study of Adderall and methylphenidate in the treatment of attention-deficit/hyperactivity disorder.

  2000cited by this paper
• Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with Attention-deficit/hyperactivity disorder.

  1999cited by this paper
• Short-Term Side Effects of Stimulant Medication Are Increased in Preschool Children with Attention-Deficit/Hyperactivity Disorder: A Double-Blind Placebo-Controlled Study

  1998cited by this paper
• mCPP-induced anxiety in the light-dark box in rats – a new method for screening anxiolytic activity

  1998cited by this paper
• Bias in meta-analysis detected by a simple, graphical test

  1997cited by this paper
• Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms. A randomized, double-blind, placebo-controlled trial.

  1997cited by this paper
• Methylphenidate dosing: twice daily versus three times daily.

  1996cited by this paper
• Pindolol and methylphenidate in children with attention-deficit hyperactivity disorder. Clinical efficacy and side-effects.

  1996cited by this paper
• Prediction of clinical response to methylphenidate in children with attention-deficit hyperactivity disorder.

  1995cited by this paper
• Placebo-controlled evaluation of Ritalin side effects.

  1993cited by this paper
• A fully automated light/dark apparatus useful for comparing anxiolytic agents.

  1991cited by this paper
• Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation.

  1990cited by this paper
• HYPERACTIVE CHILDREN GROWN UP

  1986cited by this paper
• Methylphenidate in hyperactive children: Differential effects of dose on academic, learning, and social behavior

  1985cited by this paper
• Pemoline, methylphenidate, and placebo in children with minimal brain dysfunction.

  1980cited by this paper
• Imipramine and methylphenidate in hyperactive children.

  1980cited by this paper
• Comparative effects of methylphenidate and thioridazine in hyperkinetic children. I. Clinical results.

  1976cited by this paper

• Does age of ADHD medication initiation predict long-term risk of anxiety? A scoping review

  2025cites this paper
• Animal models of attention-deficit/hyperactivity disorder: Diversity and validity.

  2025cites this paper
• Remote monitoring of wide-ranging real-world changes in adults following ADHD medication initiation

  2025cites this paper
• Comorbid Autism, Anxiety, and ADHD in a Preadolescent Boy: Clinical Opportunities.

  2025cites this paper
• Change in vital parameters at first methylphenidate administration as a predictor of treatment response at six-month follow-up

  2025cites this paper
• Adult ADHD and comorbid anxiety and depressive disorders: a review of etiology and treatment

  2025cites this paper
• Examining the roles of working memory and trait anxiety on math achievement in children with ADHD.

  2025cites this paper
• Practice Pearls for Stimulant Treatment of Attention-Deficit/Hyperactivity Disorder in Youth.

  2024cites this paper
• ADHD in Adults with Epilepsy: A Guide for Neurologists

  2024cites this paper
• Effects of ADHD and ADHD medications on depression and anxiety in children and adolescents: A systematic review and meta-analysis.

  2024cites this paper
• The use of dextroamphetamine/amphetamine to treat attention-deficit/hyperactivity disorder comorbid with borderline personality disorder: A case report

  2024cites this paper
• Effect of pharmacological treatment of attention-deficit/hyperactivity disorder on later psychiatric comorbidity: a population-based prospective long-term study

  2024cites this paper
• From Consensus Statement to Pills to Pixels: New Innovations in Attention-Deficit/Hyperactivity Disorder Care

  2024cites this paper
• Anxiety and Somatic Symptoms in Children and Adolescents Diagnosed with Attention-Deficit Hyperactivity Disorder

  2023cites this paper
• Revisiting stimulant use for emotional dysregulation in attention-deficit/hyperactivity disorder (ADHD)

  2023cites this paper
• Bootstrap-Based Between-Study Heterogeneity Tests in Meta-Analysis

  2022cites this paper
• Psychosocial Interventions for Attention Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis by the CADDRA Guidelines Work GROUP

  2022cites this paper
• A meta-analytic review of the impact of ADHD medications on anxiety and depression in children and adolescents

  2022influential citation
• From Structural Disparities to Neuropharmacology: A Review of Adult Attention-Deficit/Hyperactivity Disorder Medication Treatment.

  2022cites this paper
• Association Between Mild Neurocognitive Disorder Due to Alzheimer's Disease and Possible Attention-deficit/Hyperactivity Disorder: A Case Report.

  2022cites this paper
• ADHD and Anxiety Disorder Comorbidity in Children and Adults: Diagnostic and Therapeutic Challenges

  2022cites this paper
• Psychological Strategies for Dealing with Mental Disorders in the Preoperative and Postoperative Period

  2022cites this paper
• Effects of prolonged methylphenidate treatment on amygdala reactivity and connectivity: a randomized controlled trial in stimulant treatment-naive, male participants with ADHD

  2021cites this paper
• Specialty knowledge and competency standards for pharmacotherapy for pediatric obsessive-compulsive disorder.

  2021cites this paper
• The World Federation of ADHD International Consensus Statement: 208 Evidence-based Conclusions about the Disorder.

  2021cites this paper
• Stimulant Treatment Effect on Anxiety Domains in Children with Attention-Deficit/Hyperactivity Disorder With and Without Anxiety Disorders: A 12-Week Open-Label Prospective Study

  2021cites this paper
• Prolonged Exposure Therapy: A Case of Comorbid PTSD, ADHD, and GAD

  2021cites this paper
• Pharmacotherapy of attention-deficit hyperactivity disorder: common quandaries, dilemmas and challenges.

  2020cites this paper
• Society for Developmental and Behavioral Pediatrics Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents with Complex Attention-Deficit/Hyperactivity Disorder.

  2020cites this paper
• Addressing mental health needs: an integral part of COVID‐19 response

  2020cites this paper
• Safety of 80 antidepressants, antipsychotics, anti‐attention‐deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta‐review of 78 adverse effects

  2020cites this paper
• Management of anxiety disorders in children with attention-deficit hyperactivity disorder: a narrative review

  2020cites this paper
• The Diagnosis and Management of Anxiety in Adolescents With Comorbid ADHD

  2020cites this paper
• Comorbidity between ADHD and anxiety disorders across the lifespan

  2019cites this paper
• Adverse Drug Reactions Related to Mood and Emotion in Pediatric Patients Treated for Attention Deficit/Hyperactivity Disorder: A Comparative Analysis of the US Food and Drug Administration Adverse Event Reporting System Database.

  2019cites this paper
• Childhood methylphenidate adherence as a predictor of antidepressants use during adolescence

  2019cites this paper
• Methylphenidate Dose-Dependently Affects Aggression and Improves Fear Extinction and Anxiety in BALB/cJ Mice

  2019cites this paper
• Pre-Existing Comorbid Emotional Symptoms Moderate Short-Term Methylphenidate Adverse Effects in a Randomized Trial of Children with Attention-Deficit/Hyperactivity Disorder

  2019cites this paper
• Cognitive-Behavioral Therapy for Adult ADHD: A Randomized Clinical Trial in China

  2019cites this paper
• Neural Mechanisms underlying Cognitive Control of Aggression

  2019cites this paper
• Treatments for Obsessive-Compulsive Disorder and Comorbid Disorders

  2019cites this paper
• Effect of Methylphenidate on State Anxiety in Children With ADHD-A Single Dose, Placebo Controlled, Crossover Study

  2019cites this paper
• Pharmacological treatment of attention-deficit hyperactivity disorder comorbid with an anxiety disorder: a systematic review

  2019cites this paper
• Disturbo di deficit dell⬢attenzione/iperattività nel bambino: approccio medico

  2019cites this paper
• The impact of attention deficit hyperactivity disorder in obsessive‐compulsive disorder subjects

  2019cites this paper
• Systemic oxytocin administration alters mesolimbic dopamine release in mice.

  2019cites this paper
• Effects of methylphenidate treatment on quality of life in adolescents

  2018cites this paper
• Treatment Implications for ADHD Youth with Mood and Anxiety Comorbidity

  2018cites this paper
• Comorbidity of ADHD with Anxiety Disorders and Obsessive Compulsive Disorder

  2018cites this paper
• Psychoactive drug exposure during breastfeeding: a critical need for preclinical behavioral testing

  2018cites this paper
• Trouble déficit de l'attention/hyperactivité chez l'enfant : approche médicale

  2018cites this paper
• Treatment strategies for ADHD: an evidence-based guide to select optimal treatment

  2018cites this paper
• Adverse drug events related to mood and emotion in paediatric patients treated for ADHD: A meta-analysis.

  2018cites this paper
• A Systematic Review of the Use of Bupropion for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents

  2017cites this paper
• A Bayesian “Fill-In” Method for Correcting for Publication Bias in Meta-Analysis

  2017cites this paper
• Extended Release Guanfacine in Pediatric Anxiety Disorders: A Pilot, Randomized, Placebo-Controlled Trial

  2017cites this paper
• Discontinuation of pharmacological treatment of children and adolescents with attention deficit hyperactivity disorder: meta-analysis of 63 studies enrolling 11,788 patients

  2017cites this paper
• Stimulant medication to treat attention-deficit/hyperactivity disorder

  2017cites this paper
• Gastrointestinal adverse events during methylphenidate treatment of children and adolescents with attention deficit hyperactivity disorder: A systematic review with meta-analysis and Trial Se q uential Analysis of

  2017cites this paper
• Temporary Removal: Psychopharmacotherapy of Adhd Complex Presentations

  2017cites this paper
• A review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbidities

  2017cites this paper
• Treatments and compositions for attention deficit hyperactivity disorder: a patent review

  2016cites this paper
• A possible effect of methylphenidate on state anxiety: A single dose, placebo controlled, crossover study in a control group.

  2016cites this paper
• UvA-DARE ( Digital Academic Repository ) Cognition and comorbidity in ADHD : The role of methylphenidate and development

  2016influential citation
• Cognition and comorbidity in ADHD: The role of methylphenidate and development

  2016cites this paper
• Stimulants Use in Attention Deficit Hyperactivity Disorder (ADHD) Kids - Triumph or Tribulation?

  2016cites this paper
• Primary Pediatric Care Psychopharmacology: Focus on Medications for ADHD, Depression, and Anxiety.

  2016cites this paper
• Trouble déficit de l’attention/hyperactivité chez l’enfant et l’adolescent

  2016cites this paper
• The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder Neuroscience and Biobehavioral Reviews

  year unknowncites this paper